Amerise Biosciences Balance Sheet Health
Financial Health criteria checks 3/6
Amerise Biosciences has a total shareholder equity of ₹52.9M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹53.3M and ₹389.0K respectively.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | n/a |
| Cash | ₹159.00k |
| Equity | ₹52.92m |
| Total liabilities | ₹389.00k |
| Total assets | ₹53.31m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531681's short term assets (₹178.0K) do not cover its short term liabilities (₹388.0K).
Long Term Liabilities: 531681's short term assets (₹178.0K) exceed its long term liabilities (₹1,000.0).
Debt to Equity History and Analysis
Debt Level: 531681 is debt free.
Reducing Debt: 531681 has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 531681 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 531681 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.4% each year